Herbalife Q3 net sales $1.3B (+2.7% YoY), adj. EBITDA $163M beats guidance; tightens FY25 ranges

HERBALIFE LTD.

2025-Q3 EPS reported $1.38 revenue$3,754,500,000

Net sales $1.3B, above guidance midpoint; up 2.7% YoY (3.2% constant currency).
North America returned to growth with +1.0% YoY, first quarterly gain since Q2 '21.
Adjusted EBITDA $163.0M exceeds guidance; Adjusted EPS $0.50; Net income $43.2M.
Repaid $147.3M of 2025 Notes; leverage ratio reduced to 2.8x.
Full-year guidance tightened: net sales and adj. EBITDA ranges narrowed; Q4 guidance provided.

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-106671
form_type: 8-K
ticker: HLF
cik: 0001180262
company_name: HERBALIFE LTD.
filed_at: 2025-11-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.943728+00:00
generated_at: 2026-05-17T00:11:24.939538+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-106671
json_url: https://secwatch.observer/filing/0001213900-25-106671.json
markdown_url: https://secwatch.observer/filing/0001213900-25-106671.md
text_url: https://secwatch.observer/filing/0001213900-25-106671.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1180262/000121390025106671/0001213900-25-106671-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1180262/000121390025106671/ea0264084-8k_herbalife.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-25-106671

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.